Combined Chemotherapy and Radiation for Bulky Stages I-II Cervical Cancer: Comparison of Concurrent and Sequential Regimens

Tchan Kyu Park, Sung Ki Lee, Soo Nyung Kim, Tai Sik Hwang, Gwi Eon Kim, Chang-Ok Suh, Juhn Kyu Loh

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Based on analysis of 5-year survival rates among 386 patients with carcinoma of the cervix treated between 1976 and 1984 at Yonsei University College of Medicine, high risk factors have been defined which identify patients with a poor prognosis when treated with radiation alone. Among patients with FIGO Stages I-II disease, lesions ≥4 cm were indicative of a higher risk of treatment failure. Between 1984 and 1991, 39 patients with Stages I-II large cell squamous cancers ≥4 cm in diameter were treated with radiation alone. Between 1984 and 1989, 19 comparable patients were treated with sequential chemotherapy consisting of two or three cycles of cisplatin at 100 mg/m2 and a 5-day infusion of 5-fluorouracil at 1000 mg/m2/24 hr. Between 1988 and 1991, 37 comparable patients were treated with concurrent radiation and one to six cycles of chemotherapy employing the same or equivalent drug and dose schedule. The radiation techniques, dose, and fractionation employed were similar in the three groups. The 30-month survival rate was 100, 89.5, and 79.5% (P < 0.05) following concurrent treatment, sequential treatment, and radiation alone, respectively. Response to chemotherapy administered in cycles was evaluated before instituting radiotherapy in the patients treated with sequential chemotherapy and radiation. In conclusion, the combination of radiotherapy and chemotherapy appeared superior to radiation alone, and the toxicity of combined modality therapy is manageable. Also concurrent chemotherapy may be slightly better than sequential chemotherapy and radiation, and given the lesser overall treatment time and expense, this has become the preferred mode of treatment in our institution.

Original languageEnglish
Pages (from-to)196-201
Number of pages6
JournalGynecologic Oncology
Volume50
Issue number2
DOIs
Publication statusPublished - 1993 Jan 1

Fingerprint

Uterine Cervical Neoplasms
Radiation
Drug Therapy
Radiotherapy
Survival Rate
Dose Fractionation
Squamous Cell Neoplasms
Combined Modality Therapy
Therapeutics
Combination Drug Therapy
Treatment Failure
Cervix Uteri
Fluorouracil
Cisplatin
Appointments and Schedules
Medicine
Carcinoma
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Park, Tchan Kyu ; Lee, Sung Ki ; Kim, Soo Nyung ; Hwang, Tai Sik ; Kim, Gwi Eon ; Suh, Chang-Ok ; Loh, Juhn Kyu. / Combined Chemotherapy and Radiation for Bulky Stages I-II Cervical Cancer : Comparison of Concurrent and Sequential Regimens. In: Gynecologic Oncology. 1993 ; Vol. 50, No. 2. pp. 196-201.
@article{b4b69406f6ca4b709f1ab5be3549c16c,
title = "Combined Chemotherapy and Radiation for Bulky Stages I-II Cervical Cancer: Comparison of Concurrent and Sequential Regimens",
abstract = "Based on analysis of 5-year survival rates among 386 patients with carcinoma of the cervix treated between 1976 and 1984 at Yonsei University College of Medicine, high risk factors have been defined which identify patients with a poor prognosis when treated with radiation alone. Among patients with FIGO Stages I-II disease, lesions ≥4 cm were indicative of a higher risk of treatment failure. Between 1984 and 1991, 39 patients with Stages I-II large cell squamous cancers ≥4 cm in diameter were treated with radiation alone. Between 1984 and 1989, 19 comparable patients were treated with sequential chemotherapy consisting of two or three cycles of cisplatin at 100 mg/m2 and a 5-day infusion of 5-fluorouracil at 1000 mg/m2/24 hr. Between 1988 and 1991, 37 comparable patients were treated with concurrent radiation and one to six cycles of chemotherapy employing the same or equivalent drug and dose schedule. The radiation techniques, dose, and fractionation employed were similar in the three groups. The 30-month survival rate was 100, 89.5, and 79.5{\%} (P < 0.05) following concurrent treatment, sequential treatment, and radiation alone, respectively. Response to chemotherapy administered in cycles was evaluated before instituting radiotherapy in the patients treated with sequential chemotherapy and radiation. In conclusion, the combination of radiotherapy and chemotherapy appeared superior to radiation alone, and the toxicity of combined modality therapy is manageable. Also concurrent chemotherapy may be slightly better than sequential chemotherapy and radiation, and given the lesser overall treatment time and expense, this has become the preferred mode of treatment in our institution.",
author = "Park, {Tchan Kyu} and Lee, {Sung Ki} and Kim, {Soo Nyung} and Hwang, {Tai Sik} and Kim, {Gwi Eon} and Chang-Ok Suh and Loh, {Juhn Kyu}",
year = "1993",
month = "1",
day = "1",
doi = "10.1006/gyno.1993.1192",
language = "English",
volume = "50",
pages = "196--201",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Combined Chemotherapy and Radiation for Bulky Stages I-II Cervical Cancer : Comparison of Concurrent and Sequential Regimens. / Park, Tchan Kyu; Lee, Sung Ki; Kim, Soo Nyung; Hwang, Tai Sik; Kim, Gwi Eon; Suh, Chang-Ok; Loh, Juhn Kyu.

In: Gynecologic Oncology, Vol. 50, No. 2, 01.01.1993, p. 196-201.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combined Chemotherapy and Radiation for Bulky Stages I-II Cervical Cancer

T2 - Comparison of Concurrent and Sequential Regimens

AU - Park, Tchan Kyu

AU - Lee, Sung Ki

AU - Kim, Soo Nyung

AU - Hwang, Tai Sik

AU - Kim, Gwi Eon

AU - Suh, Chang-Ok

AU - Loh, Juhn Kyu

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Based on analysis of 5-year survival rates among 386 patients with carcinoma of the cervix treated between 1976 and 1984 at Yonsei University College of Medicine, high risk factors have been defined which identify patients with a poor prognosis when treated with radiation alone. Among patients with FIGO Stages I-II disease, lesions ≥4 cm were indicative of a higher risk of treatment failure. Between 1984 and 1991, 39 patients with Stages I-II large cell squamous cancers ≥4 cm in diameter were treated with radiation alone. Between 1984 and 1989, 19 comparable patients were treated with sequential chemotherapy consisting of two or three cycles of cisplatin at 100 mg/m2 and a 5-day infusion of 5-fluorouracil at 1000 mg/m2/24 hr. Between 1988 and 1991, 37 comparable patients were treated with concurrent radiation and one to six cycles of chemotherapy employing the same or equivalent drug and dose schedule. The radiation techniques, dose, and fractionation employed were similar in the three groups. The 30-month survival rate was 100, 89.5, and 79.5% (P < 0.05) following concurrent treatment, sequential treatment, and radiation alone, respectively. Response to chemotherapy administered in cycles was evaluated before instituting radiotherapy in the patients treated with sequential chemotherapy and radiation. In conclusion, the combination of radiotherapy and chemotherapy appeared superior to radiation alone, and the toxicity of combined modality therapy is manageable. Also concurrent chemotherapy may be slightly better than sequential chemotherapy and radiation, and given the lesser overall treatment time and expense, this has become the preferred mode of treatment in our institution.

AB - Based on analysis of 5-year survival rates among 386 patients with carcinoma of the cervix treated between 1976 and 1984 at Yonsei University College of Medicine, high risk factors have been defined which identify patients with a poor prognosis when treated with radiation alone. Among patients with FIGO Stages I-II disease, lesions ≥4 cm were indicative of a higher risk of treatment failure. Between 1984 and 1991, 39 patients with Stages I-II large cell squamous cancers ≥4 cm in diameter were treated with radiation alone. Between 1984 and 1989, 19 comparable patients were treated with sequential chemotherapy consisting of two or three cycles of cisplatin at 100 mg/m2 and a 5-day infusion of 5-fluorouracil at 1000 mg/m2/24 hr. Between 1988 and 1991, 37 comparable patients were treated with concurrent radiation and one to six cycles of chemotherapy employing the same or equivalent drug and dose schedule. The radiation techniques, dose, and fractionation employed were similar in the three groups. The 30-month survival rate was 100, 89.5, and 79.5% (P < 0.05) following concurrent treatment, sequential treatment, and radiation alone, respectively. Response to chemotherapy administered in cycles was evaluated before instituting radiotherapy in the patients treated with sequential chemotherapy and radiation. In conclusion, the combination of radiotherapy and chemotherapy appeared superior to radiation alone, and the toxicity of combined modality therapy is manageable. Also concurrent chemotherapy may be slightly better than sequential chemotherapy and radiation, and given the lesser overall treatment time and expense, this has become the preferred mode of treatment in our institution.

UR - http://www.scopus.com/inward/record.url?scp=0027279620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027279620&partnerID=8YFLogxK

U2 - 10.1006/gyno.1993.1192

DO - 10.1006/gyno.1993.1192

M3 - Article

C2 - 8375735

AN - SCOPUS:0027279620

VL - 50

SP - 196

EP - 201

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -